Precision Oncology Diagnostics Market

Precision Oncology Diagnostics Market Share & Analysis – Industry Overview

Base Year: 2024 Historical Data: 2021-23
  • Report ID: TBI-14776
  • Published Date: Jun, 2025
  • Pages: 236
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

Segment Analysis

Regional segmentation analysis

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global precision oncology diagnostics market, with a 40% market revenue share in 2024.

This region has a developed healthcare system, supported by well-known hospitals, doctoral research entities and advanced diagnostic laboratories. A key reason North America leads is the huge investment in research and development made by both government and private companies. In the United States, much of the world’s financial support for precision medicine is concentrated on NGS, identifying biomarkers and improving companion diagnostics. Thanks to its powerful research and development community, it’s possible to create and commercialize new diagnostic tests driving the regional market’s growth. The region is aided by regulations that make it faster and easier for precision oncology diagnostics to get approval and become available. On top of this, having many cases of cancer and more people aware of their health is why demand for new kinds of diagnostics and targeted drugs is rising.

North America Region Precision Oncology Diagnostics Market Share in 2024 - 40%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

  • Spesana's best-in-class portfolio of clinical collaboration, patient navigation, and oncology clinical decision support tools was acquired by Aranscia, a global provider of award-winning clinical workflow and diagnostic technology solutions. Carla Balch, the founder and CEO of Spesana and a well-known pioneer in the fields of healthcare and oncology information systems, will take on the position of Executive Director for all Aranscia software products as part of the acquisition. Managing Spesana's ongoing technological and commercial growth is part of this.

Technology Segment Analysis

The technology segment is divided into Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Immunohistochemistry (IHC), Microarray and others. The Next-Generation Sequencing (NGS) segment dominated the market, with a market share of around 37% in 2024. NGS is leading the way in precision oncology diagnostics given its unique high-throughput genome analysis. NGS is different from PCR and microarrays because it can test hundreds of thousands of fragments in one look, uncovering mutations and biomarkers in different genes all at the same time. The importance of this capacity appears in oncology, as spotting many forms of genetic changes helps doctors choose the best targeted treatments. Scalability and speed are among the main benefits of NGS. Improvements in sequencing technology and lower costs make it more accessible and affordable, thereby by making NGS more popular in both hospital and laboratory settings. Its versatility enables it's use with tissue biopsies and blood samples which makes it helpful for both diagnosis and progress monitoring. NGS helps oncologists decide if patients are eligible for the targeted drugs designed for their disease. It also helps find biomarkers and develop individualized treatments. The use of NGS together with advanced bioinformatics and AI technology helps clarify complex data, increase the accuracy of diagnosis and support clinical trials. Basically, NGS is dominant in this market because it has extensive features, is becoming cheaper and ensures cancer can be treated in a personalized way. Its ongoing development will probably maintain its strength in oncology, making care more effective and adapted to individual patients.

  • In order to introduce Stratipath Breast, an AI-based prognostic risk profile tool, to healthcare practitioners in the UK and Europe, Diagnexia has partnered with Stratipath AB. Through this partnership, Diagnexia's digital pathology network and Stratipath's technology are combined to provide quicker and more accurate cancer diagnosis. The collaboration seeks to enhance the process of choosing treatments for breast cancer. Stratipath Breast classifies tumours into high- and low-risk groups by analysing standard H&E-stained slides. It lowers expenses and makes precision oncology more accessible by producing quick results in less than an hour. In order to improve workflow efficiency and assist clinicians in making treatment decisions, Diagnexia intends to broaden the application of AI-based diagnostics.

Application Segment Analysis

The application segment is divided into biomarker discovery, companion diagnostics, prognostics, monitoring and recurrence and early detection and screening. The biomarker discovery segment dominated the market, with a market share of around 35% in 2024. The importance of personalized cancer care and targeted therapy development makes biomarker discovery the leading technology in this market. Biomarkers are molecules found in our biology—such as genes, proteins or mutations—that mark the beginning, changes or details of cancer. Discovering trustworthy biomarkers helps in understanding cancer, predicting therapy effects and guiding medicine in choosing clinical approaches. Enhancing cancer diagnosis, prognosis and choosing the best treatment are the main reasons why biomarker discovery is so important. The use of high-throughput methods such as next-generation sequencing and proteomics, has greatly improved the way biomarkers are discovered in tumours. Moreover, discovering biomarkers helps produce companion diagnostics which are necessary to find the best targeted therapies and immunotherapies for patients. In addition, studying biomarkers makes it possible to detect and monitor cancer at an earlier stage, so treatment can be given sooner. Biomarker discovery is a major priority for pharmaceutical and research groups, as they believe it improves their performance and advances innovation in cancer medicine.

  • Ataraxis AI, a medical technology business based in New York, has announced $4 million in seed funding, coming out of stealth mode. The startup is focused on creating cancer diagnostics powered by artificial intelligence (AI) that can assist doctors in determining the best course of treatment for their patients and forecasting their prognosis. Ataraxis launched its first test, Ataraxis Breast, concurrently with the announcement of its launch and seed funding. According to the business, this is the first AI-native prognostic/predictive test for breast cancer in the world.

Cancer Type Segment Analysis

The cancer type segment is divided into lung cancer, breast cancer, colorectal cancer, prostate cancer, leukemia and others. The lung cancer segment dominated the market, with a market share of around 34% in 2024. Lung cancer is the number one reason for the growth of precision oncology diagnostics because it is commonly found, has a high death rate and strongly requires personalized treatments. Due to the variation between lung tumours, it is important to have precise diagnostics because they let doctors find the unique genetic changes and chemical markers that drive treatment plans. Moreover, the market for oncology is dominated by lung cancer since there are many molecular targets, for which some targeted therapies have been approved. Additionally, there is a strong need for improved ways to diagnose and treat lung cancer which drives substantial funding from the pharmaceutical sector, research groups and healthcare providers to improve precision oncology diagnostics.

End-User Segment Analysis

The end-user segment is divided into hospitals & clinics, diagnostic laboratories, academic & research institutes and biopharmaceutical companies. The hospitals & clinics segment dominated the market, with a share of around 38% in 2024. Hospitals and clinics, as the main providers of cancer care, take up the largest share of users in the precision oncology diagnostics market. They are key places where cancer patients are diagnosed, have their treatment outline created and are monitored over time, so precision diagnostics can happen there. Advanced testing equipment in extended care allows oncologists to review full genetic and molecular information about patients before making treatment decisions. An important reason why cancer care is so effective is that qualified experts including oncologists, pathologists and genetic counsellors cooperate closely in hospitals and clinics. By uniting all kinds of expertise, it becomes possible to better explain test results and choose treatments which leads to improved results for patients. Besides, hospitals and clinics generally have what it takes to carry out precision diagnostics themselves or arrange such testing with specialized laboratories. As people learn more about how effective personalized medicine can be, hospitals and clinics are adding new technologies and training to make these tests part of their routine work. Regulatory and insurance rules generally benefit practicing precision diagnostics in hospitals, leading doctors to provide these services as part of treating cancer.

Request Table of Content

+1

This study forecasts revenue at global, regional, and country levels from 2021 to 2034. The Brainy Insights has segmented the global precision oncology diagnostics market based on below mentioned segments:

Global Precision Oncology Diagnostics Market by Type:

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • In Situ Hybridization (ISH)
  • Immunohistochemistry (IHC)
  • Microarray
  • Others

Global Precision Oncology Diagnostics Market by Application:

  • Biomarker Discovery
  • Companion Diagnostics
  • Prognostics
  • Monitoring and Recurrence
  • Early Detection and Screening

Global Precision Oncology Diagnostics Market by Cancer Type:

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Leukemia
  • Others

Global Precision Oncology Diagnostics Market by End-User:

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Biopharmaceutical Companies

Global Precision Oncology Diagnostics Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date